News and Comments

THREE SMALL BIOTECH FIRMS IN THE SPOTLIGHT

  Wednesday, July 31, 2013

Three biotechnology firms with market caps below $1billion have been recently put in the spotlight; SYNTA (SNTA) with a market cap of 535.54 million, ARRAY (ARRY) with a market cap of 774.22 million, and VANDA (VNDA) with a market cap of 320.45 million. More...


Recent Postings


Archive


Tags

Prosensa (RNA) Dendreon (DNDN) Rapamune OSI (OSIP) Jazz Pharmaceuticals (JAZZ) Human Longevity (HLI) SERES THERAPEUTICS (MCRB) REGULUS (RGLS) Dynavax (DVAX) IDERA (IDRA) HALOZYME (HALO) Revlimid (lenolidamide) Ariad (ARIA) Biogen Idec (BIIB) Aimmune Therapeutics (AIMT) Roche (ROCHE) INNOVIVA (INVA) Gilead (GILD) NANTKWEST (NK) C4 Therapeutics Mirati Therapeutics (MRTX) Merck (MRK) ISIS (ISIS) Intrexon (XON) SYNTA (SNTA) Herceptin Vertex (VRTX) AGOS (ARGS) Abbott Laboratories (ABT) ZALTRAP™ Roche (RHHBY) Telaprevir AstraZeneca (AZN) Galena (GALE) Theravance Bio Pharma (TBPH) Anadys (ANDS) Multiple Myeloma Elan (ELN) Cytokinetics (CYTK) galapagos (GLPG) GUARDIAN HEALTH Ridaforolimus Zerenex MODERNA SUNESIS PHARMACEUTICALS (SNSS) Sequenom (SQNM) Ionis (IONS) Trastuzumab-DM1 PTC Therapeutics (PTCT) AERIE PHARMACEUTICALS JUNO (JUNO) Adaptimmune (ADAP) Intermune (ITMN) Biocryst (BCRX) Alder Biopharmaceuticals (ALDR) ABBVIE (ABBV) ARCA (ABIO) Intercept (ICPT) ImmunoGen (IMGN) Seattle Genetics (SGEN) Anacor (ANAC) Human Genome Sciences (HGSI) Incyte (INCY) Sangamo (SGMO) Bellicum (BLCM) Theravance (THRX) Genentech CompuGen (CGEN) Global Cell Therapeutics (GBT) Vitae Pharmaceuticals (VTAE) Benlysta (belimumab) TOKAI (TKAOI) Spike Therapeutics (ONCE) Array Pharmaceuticals (ARRY) Onyx (ONXX) ADVENTRIX (ANX) Idenix (IDIX) BIOMARIN (BMRN) Exelixis (EXEL) Regeneron (REGN) GlaxoSmithKline (GSK) Ziofpharm (ZIOP) KITE (KITE) Sanofi (SNA) Sanofi (SNY) Xoma (XOMA) Pluristem (PSTI) NOVOCURE (NVCR) Micromet (MITI) Valeant Pharmaceuticals International (VRX) Sarepta (SRPT) Agenus (AGEN VANDA (VNDA) Inovio (INO) Bristol-Myers Squibb (BMY) Alnylam (ALNY) Agenus (AGEN) Amgen (AMGN) Tysabri ACADIA (ACAD) ARGOS (ARGS) Velcade (bortezomib) Editas (EDIT) Advaxis (ADXS) NEKTAR (NKTR)) Prolor Biotech (PBTH) RenenxBio (RGNX) Auspex (ASPX) Endometrial Cancer KERYX (KERX) Illumina (ILMN) Sanofi-Aventis (SAN)